-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Saturday, Dr. Reddy's Breaks Ground As First Generic Semaglutide Injection Launcher In Canada, Expanding Global GLP-1 Therapy Access

Benzinga·05/18/2026 07:15:41
Listen to the news
  • The launch follows Dr. Reddy's receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company's readiness to serve Canadian patients
  • Dr. Reddy's is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
  • Canada is the first G7 country to grant market authorization for generic Semaglutide Injection